Coeptis Therapeutics, Inc. Increase (Decrease) in Contract with Customer, Liability
Coeptis Therapeutics, Inc. reported Increase (Decrease) in Contract with Customer, Liability of -$1.00 million for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2021-11-15
- Coeptis Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-09-30 was -$1.00M.
- Coeptis Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- Coeptis Therapeutics, Inc. increase (decrease) in contract with customer, liability for the quarter ending 2020-09-30 was $0.00.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month |
|---|---|---|---|
| 2021-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | -$1.00M derived: sum of 2 quarters · filed 2021-11-15 | -$1.00M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | $0.00 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $0.00 10-Q/A · filed 2021-05-18 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $250.00K derived: sum of 2 quarters · filed 2021-11-15 | $500.00K 10-Q · filed 2021-11-15 |
| 2020-06-30 | $250.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2021-08-16 | $500.00K 10-Q · filed 2021-08-16 | |
| 2020-03-31 | $250.00K 10-Q/A · filed 2021-05-18 |